Article
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
European journal of cancer (Oxford, England : 1990) - 1 Feb 2017
Applebaum Mark A, Vaksman Zalman, Lee Sang Mee, Hungate Eric A, Henderson Tara O, London Wendy B, Pinto Navin, Volchenboum Samuel L, Park Julie R, Naranjo Arlene, Hero Barbara, Pearson Andrew D, Stranger Barbara E, Cohn Susan L, Diskin Sharon J
Abstract excerpt
BACKGROUND: The incidence of second malignant neoplasm (SMN) within the first ten years of diagnosis in high-risk neuroblastoma patients treated with modern, intensive therapy is unknown. Further, the underlying germline genetics that contribute to SMN in these survivors are not known. METHODS: The International Neuroblastoma Risk Group (INRG) database of patients diagnosed from 1990 to 2010 was analysed. SMN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.